|
NOVARTIS AG ADS, (NVS) Stock Research Free Stock Rating
|
|
| |
| Company Profile |
| |
|
Novartis AG engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in three divisions: Pharmaceuticals, Consumer Health, and Sandoz. Pharmaceuticals division develops, markets, and sells branded pharmaceuticals in various therapeutic areas, including cardiovascular and metabolism, neuroscience, respiratory and dermatology, specialty medicines, oncology and hematology, transplantation and immunology, and ophthalmic diseases, as well as arthritis, bone, gastrointestinal, hormone replacement therapy, and infectious diseases. Consumer Health division operates five units, such as over-the-counter self-medication products, animal health, medical nutrition, infant and baby foods, and lens and vision care. Sandoz division develops, manufactures, markets, and sells retail generics drugs, and off-patent active pharmaceutical ingredients and intermediates to wholesalers, pharmacies, hospitals, and other healthcare outlets. It also provides biopharmaceutical products, such as protein hormones and other human proteins. The company sells its products to physicians, pharmacists, hospitals, insurance groups, and managed care organizations. Novartis was formed in 1996 as a result of the merger between Sandoz AG and CIBA-Geigy AG. The company is headquartered in Basel, Switzerland.
|
NOVARTIS AG ADS Related |
|
NVS: Profile for Novartis AG Basel - Yahoo! Finance See the company profile for Novartis AG Basel (NVS) including business summary, industry/sector information, number of employees, business summary, corporate ...
|
|
NVS: Summary for Novartis AG Basel - Yahoo! Finance Get detailed information on Novartis AG Basel (NVS) including quote performance, Real-Time ECN, technical chart analysis, key stats, insider transactions, and the ...
|
|
NVS NOVARTIS AG ADS NVS (NOVARTIS AG ADS): Stock analyses and research by investors on UpDown.com ... 6.11. NOVARTIS AG ADS (NVS) News & Analysis. View more. Stocks Offering ' ...
|
|
